Rapport Therapeutics
RAPP
Insider trades and stock quote 2024-2026
All insider trades at Rapport Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/27/2026
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$42.4 |
$93,061 |
|
7/14/2026
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$40.2 |
$328,437 |
|
6/30/2026
|
Sell |
Gault, Cheryl |
Chief Operating Officer |
$41.7 |
$415,799 |
|
6/29/2026
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$40.0 |
$327,398 |
|
5/26/2026
|
Sell |
Third Rock Ventures V, L.p. |
Ten Percent Owner |
$40.0 |
$743,753 |
|
5/11/2026
|
Sell |
Third Rock Ventures V, L.p. |
Ten Percent Owner |
$40.2 |
$5,377,323 |
|
5/8/2026
|
Sell |
Third Rock Ventures V, L.p. |
Ten Percent Owner |
$40.3 |
$202,256 |
|
5/7/2026
|
Sell |
Third Rock Ventures V, L.p. |
Ten Percent Owner |
$40.1 |
$10,892,651 |
|
4/17/2026
|
Sell |
Yeleswaram, Krishnaswamy |
Chief Development Officer |
$40.0 |
$808,844 |
|
4/17/2026
|
Sell |
Third Rock Ventures V, L.p. |
Ten Percent Owner |
$40.3 |
$17,175,244 |
|
4/14/2026
|
Sell |
Yeleswaram, Krishnaswamy |
Chief Development Officer |
$35.1 |
$357,797 |
|
4/13/2026
|
Sell |
Yeleswaram, Krishnaswamy |
Chief Development Officer |
$35.0 |
$320,537 |
|
4/10/2026
|
Sell |
Yeleswaram, Krishnaswamy |
Chief Development Officer |
$35.0 |
$17,490 |
|
4/8/2026
|
Sell |
Yeleswaram, Krishnaswamy |
Chief Development Officer |
$34.9 |
$12,564 |
|
3/30/2026
|
Sell |
Gault, Cheryl |
Chief Operating Officer |
$28.3 |
$281,857 |
|
3/25/2026
|
Sell |
Yeleswaram, Krishnaswamy |
Chief Development Officer |
$30.0 |
$303,355 |
|
3/5/2026
|
Sell |
Gault, Cheryl |
Chief Operating Officer |
$28.9 |
$58,265 |
|
2/18/2026
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$29.4 |
$320,373 |
|
2/17/2026
|
Sell |
Bredt, David |
Chief Scientific Officer |
$28.9 |
$246,655 |
|
1/20/2026
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$26.1 |
$285,070 |
|
1/15/2026
|
Sell |
Bredt, David |
Chief Scientific Officer |
$27.1 |
$228,132 |
|
12/31/2025
|
Sell |
Yeleswaram, Krishnaswamy |
Chief Development Officer |
$30.0 |
$85,342 |
|
12/31/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$30.0 |
$197,338 |
|
12/17/2025
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$30.0 |
$323,509 |
|
12/15/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$30.3 |
$255,130 |
|
11/26/2025
|
Sell |
Gault, Cheryl |
Chief Operating Officer |
$30.1 |
$150,487 |
|
11/17/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$25.1 |
$214,091 |
|
11/17/2025
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$25.2 |
$275,048 |
|
10/15/2025
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$26.0 |
$281,729 |
|
10/15/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$26.0 |
$219,197 |
|
9/17/2025
|
Sell |
Ceesay, Abraham |
Chief Executive Officer |
$26.6 |
$2,011,197 |
|
9/15/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$24.3 |
$205,649 |
|
9/12/2025
|
Buy |
Paul, Steven M. |
Director |
$24.7 |
$1,027,112 |
|
9/12/2025
|
Buy |
Huber, Reid M. |
Director |
$24.5 |
$499,374 |
|
9/11/2025
|
Buy |
Young, Wendy B. |
Director |
$22.6 |
$79,100 |
|
9/8/2025
|
Sell |
Gault, Cheryl |
Chief Operating Officer |
$38.3 |
$191,650 |
|
8/15/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$15.4 |
$127,466 |
|
7/15/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$14.0 |
$118,962 |
|
6/16/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$11.0 |
$93,522 |
|
5/15/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$9.6 |
$81,262 |
|
4/15/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$9.6 |
$81,310 |
|
3/14/2025
|
Sell |
Bredt, David |
Chief Scientific Officer |
$10.8 |
$92,205 |
|
3/13/2025
|
Buy |
Ignelzi, Troy A. |
Chief Financial Officer |
$10.0 |
$998 |
|
3/12/2025
|
Buy |
Young, Wendy B. |
Director |
$10.2 |
$61,250 |
|
3/12/2025
|
Buy |
Ignelzi, Troy A. |
Chief Financial Officer |
$10.1 |
$99,990 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address